PRECIGEN, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
VA
Business Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Mailing Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Phone
301-556-9900
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$126.26M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 31, 2026 | View on SEC |
| 10-K Annual financial report | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
Annual Reports
10-K
March 25, 2026
- Advancing PRGN-2012 for recurrent respiratory papillomatosis with FDA Fast Track designation.
- Strategic pivot from research-focused operations to commercialization of the UltraCAR-T platform.
Insider Trading
STRONG SELL
2 insiders
23 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.